Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatotoxicity associated with amiodarone therapy.

K K Flaharty1, S L Chase, H M Yaghsezian

  • 1Division of Clinical Pharmacology, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107.

Pharmacotherapy
|January 1, 1989
PubMed
Summary

Amiodarone can cause liver problems in many patients, sometimes leading to serious liver disease or even death. This review highlights amiodarone hepatotoxicity and its potential dangers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology of UK Military Exercise SAIF SAREEA 3: future planning for hot climates.

BMJ military health·2020
Same author

Tropical medicine teaching for combat medical technicians: experience from UK military exercise SAIF SAREEA 3.

BMJ military health·2020
Same author

Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.

Alimentary pharmacology & therapeutics·2012
Same author

Prevalence of heparin-induced antibody in African-American hemodialysis patients--comparison to non-dialysis patients.

Clinical nephrology·2009
Same author

Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.

American journal of physiology. Endocrinology and metabolism·2005
Same author

Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C.

Journal of viral hepatitis·2004

Area of Science:

  • Cardiology
  • Hepatology
  • Pharmacology

Background:

  • Amiodarone is an antiarrhythmic drug frequently used for cardiac conditions.
  • Hepatotoxicity is a known, though infrequent, adverse effect of amiodarone therapy.

Observation:

  • The case involved a patient experiencing amiodarone-induced liver injury.
  • Literature review was conducted to understand the spectrum of amiodarone hepatotoxicity.

Findings:

  • Amiodarone causes asymptomatic liver function test elevations in 15-55% of patients.
  • Symptomatic hepatic disease, including cirrhosis and chronic active hepatitis, occurs less commonly.
  • Amiodarone has been linked to at least six fatalities.

Implications:

Related Experiment Videos

  • Clinicians should be vigilant for amiodarone hepatotoxicity, even in asymptomatic patients.
  • Early recognition and management are crucial to prevent severe liver damage.
  • Awareness of amiodarone's potential for fatal liver injury is essential for patient safety.